Operating Profit تغيير تاريخ
Acadia Pharmaceuticals USD 34.94M 92.72M 2023-12
Alnylam Pharmaceuticals USD -116404000 330.27M 2023-12
Amgen USD 1.27B 819M 2023-12
BioCryst Pharmaceuticals USD -11921000 37.8M 2023-09
Biogen USD 358.9M 200.1M 2023-12
BioMarin Pharmaceutical USD 14.22M 11.44M 2023-12
Bluebird Bio USD -84729000 568K 2023-09
Cytokinetics USD -127418000 5.15M 2023-12
Daiichi Sankyo JPY 51.03B 7B 2023-09
Enanta Pharmaceuticals USD -31030000 5.68M 2023-09
Esperion Therapeutics USD -27533000 9.52M 2023-09
Gilead Sciences USD 1.61B 1.01B 2023-12
Incyte USD 187.27M 27.44M 2023-12
Ionis Pharmaceuticals USD 20.68M 166.04M 2023-12
Ironwood Pharmaceuticals USD 37.59M 2.43M 2023-12
Pfizer USD -6551000000 3.61B 2023-12
PTC Therapeutics USD -131738000 13.57M 2023-12
Roche Holding CHF 9.76B 3.84B 2023-06
Sarepta Therapeutics USD -48342000 16.82M 2023-09
TG Therapeutics USD -12485000 127.27M 2023-12
Ultragenyx Pharmaceutical USD -122049000 23.05M 2023-12
Vertex Pharmaceuticals USD 1.04B 11.7M 2023-09
Xencor USD -35009000 16.74M 2023-12



PTC Therapeutics أرباح التشغيل - القيم الحالية، والبيانات التاريخية، والتنبؤات والإحصاءات والرسوم البيانية والتقويم الاقتصادي - Mar 2024.